Fatty15 Co-Founder, Dr. Stephanie Venn-Watson, Named 2026 LA Times Life Sciences Visionary
Seraphina Therapeutics, based in San Diego, has recently gained scientific recognition for uncovering an emerging nutritional deficiency syndrome linked to C15:0. The discovery, made during efforts to enhance the health of aging Navy dolphins, showcases the importance of addressing this condition. The findings were announced on April 28, 2026, shedding light on the significance of this breakthrough in the field of nutrition and health.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments